@misc{indiciaea6e0da81d26d,
  title = {CDK9 pharmacological inhibition with PRT2527 has antitumor activity in marginal zone lymphoma models and can improve the effects of BTK, PI3K, and BCL2 inhibitors},
  author = {Cannas, E. and Arribas, A. J. and Cascione, L. and Guidetti, F. and Rinaldi, A. and Rossi, D. and Stathis, A. and Heiser, D. and Bertoni, F.},
  year = {2026},
  doi = {10.64898/2026.02.10.705084},
  url = {https://www.biorxiv.org/content/10.64898/2026.02.10.705084v1},
  note = {Source identifier: 10.64898/2026.02.10.705084}
}